Ventilator-associated pneumonia;Neumonía asociada a ventilación mecánica: Riesgos, problemas y nuevos conceptos

Medicina Intensiva

Volumn 25, Issue 3, 2001, Pages 113-123

  Guardiola, J J ^a   Sarmiento, X ^b   Rello, Y J ^c  

^a Centro Médico de Veteranos   (United States)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Mechanical ventilation; Nosocomial pneumonia

Indexed keywords

ARTIFICIAL VENTILATION; HOSPITAL INFECTION; HUMAN; LUNG COMPLICATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PNEUMONIA; REVIEW; VENTILATOR;

EID: 0035021666     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-5691(01)79664-7     Document Type: Review

References (39)

1. Diagnostic testing for ventilator-associated pneumonía
2. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments
3. Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using ventilation
4. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients
5. Diagnosis of nosocomial pneumonia in mechanically ventilated patients. Comparison of a plugged telescoping catheter with the protected specimen brush
6. Bronchoscopy for ventilator-associated pneumonia: Show me the money (outcome benefit)!
7. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group
8. The influence of mini-BAL cultures on patient outcomes: Implications for the antibiotic management of ventilator-associated pneumonia
9. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia
10. The value of routine microbial investigation in ventilator-associated pneumonia
11. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: A pilot study
12. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation
13. The pathogenesis of ventilator-associated pneumonia: II. The lower respiratory tract
14. The prevention of ventilator-associated pneumonia
15. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position
16. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: A randomised trial
17. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation
18. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
19. Pneumonia in intubated patients: Role of respiratory airway care
20. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey
21. Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously
22. The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization
23. Nutritional support in the critically ill patients. A critical review of the evidence
24. 2-antagonists for stress ulcer prophylaxis: A meta-analysis on efficacy and pneumonia rate
25. Nosocomial pneumonia and the role of gastric pH. A meta-analysis
26. Histamine-2-receptor antagonists and antacids in the critically ill population: Stress ulceration versus nosocomial pneumonia
27. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group
28. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
29. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
30. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia
31. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract
32. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery
33. Hospital-acquired pneumonia in adults: Diagnosis, assessment of Severity, initial antimicrobial therapy, and preventive strategies A consensus statement, American Thoracic Society, November 1995
34. Respiratory infectious complications in the Intensive care unit
35. Diagnostic testing for ventilator-associated pneumonia. Diagnostic testing for ventilator-associated pneumonia
36. Variations in etiology of ventilator-associated pneumonia across four treatment sites: Implications for antimicrobial prescribing practices
37. Impact of nosocomial infections on outcome: Myths and evidence
38. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit
39. New perspectives in the diagnosis of nosocomial pneumonia